A comparative overview of COVID-19, MERS and SARS: Review article
- 26 July 2020
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in International Journal of Surgery
- Vol. 81, 1-8
- https://doi.org/10.1016/j.ijsu.2020.07.032
Abstract
Following the severe acute respiratory syndrome coronavirus (SARS-CoV) and the Middle East respiratory syndrome coronavirus (MERS-CoV), a third, highly pathogenic coronavirus, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) appearing at end of 2019 led to a pandemic, increased panic and attracted global attention. This review analyzes the epidemiology, etiology, clinical characteristics, treatment and sequelae of the severe acute respiratory syndrome (SARS), the Middle East respiratory syndrome (MERS) and the 2019 novel coronavirus disease (COVID-19) to help provide direction for further studies that can help understand COVID-19.Keywords
Funding Information
- Ministry of Science and Technology of the People's Republic of China
This publication has 110 references indexed in Scilit:
- Efficient Activation of the Severe Acute Respiratory Syndrome Coronavirus Spike Protein by the Transmembrane Protease TMPRSS2Journal of Virology, 2010
- A comparative epidemiologic analysis of SARS in Hong Kong, Beijing and TaiwanBMC Infectious Diseases, 2010
- Effectiveness of Ribavirin and Corticosteroids for Severe Acute Respiratory SyndromeThe American Journal of Medicine, 2009
- The discovery of angiotensin‐converting enzyme 2 and its role in acute lung injury in miceExperimental Physiology, 2008
- Angiotensin-Converting Enzyme II in the Heart and the KidneyCirculation Research, 2006
- Use of convalescent plasma therapy in SARS patients in Hong KongEuropean Journal of Clinical Microbiology & Infectious Diseases, 2004
- Eight-Month Prospective Study of 14 Patients With Hospital-Acquired Severe Acute Respiratory SyndromeMayo Clinic Proceedings, 2004
- Initial viral load and the outcomes of SARSCMAJ : Canadian Medical Association Journal, 2004
- In vitro inhibition of severe acute respiratory syndrome coronavirus by chloroquineBiochemical and Biophysical Research Communications, 2004
- Dipeptidyl-Peptidase IV from Bench to Bedside: An Update on Structural Properties, Functions, and Clinical Aspects of the Enzyme DPP IVCritical Reviews in Clinical Laboratory Sciences, 2003